FindTrial
Sign In

Quantification of the reduction on the viral load (SARS-CoV-2) on persons with COVID-19 after gargling with Linola sept mouthwash

Quantification of the reduction on the viral load (SARS-CoV-2) on persons with COVID-19 after gargling with Linola sept mouthwash

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024412
Enrollment
80
Registered
2021-02-15
Start date
2021-02-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Group 1: 2x daily (1-0-1) use of the Linola sept mouthwash for 2x20 seconds at every use. Group 2: 2x daily (1-0-1) use of a placebo mouthwash for 2x20 seconds at every use.

Sponsors

Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie Campus Klinikum Bielefeld, Medizinische Fakultät OWL, Universität Bielefeld
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: -Willingness to participate -Signed written consent -Positive SARS-CoV-2 test using a pharyngeal swab -CT-value < 37

Exclusion criteria

Exclusion criteria: Allergies on at least one of the ingredients.

Design outcomes

Primary

MeasureTime frame
Efficiency on the reduction of the temporary viral load of a mouthwash (Linola sept) after gargling.—

Secondary

MeasureTime frame
Efficiency on the cumulative reduction of the viral load of a mouthwash (Linola sept) after gargling for more than 1 day.—

Countries

Germany

Contacts

Public ContactFrederic Meyer

Dr. Kurt Wolff GmbH & Co KG Research Department

frederic.meyer@drwolffgroup.com05218808000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026